Inventor · disambiguated record
Meena Subramanyam
Also filed as: SUBRAMANYAM MEENA
16 granted patents·4 pending applications·77 citations·filing 2006–2024
92Inventor score
Files withBIOGEN MA INC15SUBRAMANYAM MEENA2BLOOMGREN GARY L1GORELIK LEONID1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
20 records- 0194US10444234B2Assay for JC virus antibodiesBIOGEN MA INC·Filed 2016·Granted Oct 15, 2019·10 cites·53 claims
- 0292US10677803B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2018·Granted Jun 9, 2020·10 cites·16 claims
- 0391US10119976B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2014·Granted Nov 6, 2018·10 cites·26 claims
- 0491US9316641B2Assay for JC virus antibodiesGORELIK LEONID·Filed 2011·Granted Apr 19, 2016·19 cites·19 claims
- 0588US12392784B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2024·Granted Aug 19, 2025·0 cites·26 claims
- 0687US10705095B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2017·Granted Jul 7, 2020·2 cites·22 claims
- 0787US8124350B2Methods and products for evaluating an immune response to a therapeutic proteinSUBRAMANYAM MEENA·Filed 2006·Granted Feb 28, 2012·11 cites·16 claims
- 0886US9709575B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2014·Granted Jul 18, 2017·7 cites·16 claims
- 0985US8871449B2Methods and products for evaluating an immune response to a therapeutic proteinSUBRAMANYAM MEENA·Filed 2011·Granted Oct 28, 2014·8 cites·28 claims
- 1085US2025020660A1Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 1183US2025164486A1Method of assessing risk of pmlBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 1279US12031990B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2022·Granted Jul 9, 2024·0 cites·18 claims
- 1373US12066442B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 1472US12345703B2Assay for JC virus antibodiesBIOGEN MA INC·Filed 2022·Granted Jul 1, 2025·0 cites·30 claims
- 1572US11686734B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2020·Granted Jun 27, 2023·0 cites·11 claims
- 1672US11280794B2Method of assessing risk of PMLBIOGEN MA INC·Filed 2020·Granted Mar 22, 2022·0 cites·16 claims
- 1771US11287423B2Assay for JC virus antibodiesBIOGEN MA INC·Filed 2019·Granted Mar 29, 2022·0 cites·26 claims
- 1868US12105090B2Methods of treating a multiple sclerosis patient with anti-VLA-4 therapyBIOGEN MA INC·Filed 2018·Granted Oct 1, 2024·0 cites·10 claims
- 1958US2023395254A1Nausea and Vomiting Management SystemTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2041US2014322164A1Method of assessing risk of pmlBLOOMGREN GARY L·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →